Paroxysmal Hemoglobinuria, Nocturnal
4 clinical trials · Condition
◉ Watch Paroxysmal Hemoglobinuria, Nocturnal
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria (NCT03157635) | Hoffmann-La Roche | 2016-11-14 |
| Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria (NCT00130000) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-08-09 |
| Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT00122317) | Alexion Pharmaceuticals, Inc. | 2005-05-01 |
| Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria (NCT00004464) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1996-02-01 |
Track Paroxysmal Hemoglobinuria, Nocturnal automatically
Every clearance here is in the API, with alerts when new ones post.